Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$3.45 -0.14 (-3.90%)
As of: Oct 1, 2026 · 3:28 PM EDT

Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021)

Updated

Insight Molecular Diagnostics' Equity Income came in at -$270,000 for FY2021, compared with -$1.55 million in FY2020.

Analysis

Insight Molecular Diagnostics (IMDX) Equity Income (2020 - 2021) Analysis & Trends

  • Per Business Quant, earlier years put Equity Income at -$1.55 million in FY2020 and -$281,000 in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Income (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn -15.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn -
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn -
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn -
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn -
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn -
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn -
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn -
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn -
10 Insight Molecular Diagnostics 117.12 Mn 40.83 Mn 157,000.00 -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -270,000.00
Dec 31, 2020 -435,000.00
Sep 30, 2020 -482,000.00
Jun 30, 2020 -301,000.00
Mar 31, 2020 -329,000.00
API Access

Insight Molecular Diagnostics Equity Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=equity-income&ticker=IMDX&period=max&api_key=YOUR_API_KEY